FibroGen, Inc.
FGEN
$0.2912
-$0.0269-8.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.14M | 46.33M | 50.64M | 55.90M | -73.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.14M | 46.33M | 50.64M | 55.90M | -73.81M |
| Cost of Revenue | 1.03M | 27.00M | 39.28M | 64.15M | 50.47M |
| Gross Profit | 2.11M | 19.33M | 11.36M | -8.24M | -124.28M |
| SG&A Expenses | 8.35M | 17.55M | 22.28M | 22.82M | -4.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.37M | 44.56M | 61.56M | 86.97M | 45.93M |
| Operating Income | -6.23M | 1.78M | -10.92M | -31.06M | -119.74M |
| Income Before Tax | -8.66M | -17.07M | -15.81M | -32.90M | -95.15M |
| Income Tax Expenses | 2.00K | 12.00K | -262.00K | 33.00K | -175.00K |
| Earnings from Continuing Operations | -8.67M | -17.08M | -15.54M | -32.93M | -94.97M |
| Earnings from Discontinued Operations | 26.65M | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.98M | -17.08M | -15.54M | -32.93M | -56.23M |
| EBIT | -6.23M | 1.78M | -10.92M | -31.06M | -119.74M |
| EBITDA | -5.88M | 2.52M | -10.14M | -30.24M | -117.86M |
| EPS Basic | 0.18 | -0.17 | -0.16 | -0.33 | -0.57 |
| Normalized Basic EPS | -0.05 | 0.01 | -0.10 | -0.21 | -0.76 |
| EPS Diluted | 0.18 | -0.17 | -0.16 | -0.33 | -0.57 |
| Normalized Diluted EPS | -0.05 | 0.01 | -0.10 | -0.21 | -0.76 |
| Average Basic Shares Outstanding | 100.83M | 100.52M | 99.84M | 98.98M | 97.30M |
| Average Diluted Shares Outstanding | 100.83M | 100.52M | 99.84M | 98.98M | 97.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |